HANNAH BROCATO: Open Payments
NPI 1831859412 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 39 payments from 10 companies in 2025. Trend: 2023 $2,139 · 2024 $804 · 2025 $921
Food & beverage: $836Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $247 |
| Galderma Laboratories, L.P. | 8 | $173 |
| GENZYME CORPORATION | 6 | $155 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $154 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $35 |
| Smith+Nephew, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| UCB, Inc. | 1 | $17 |
Products named: DUPIXENT, NEMLUVIO, COSENTYX, ILUMYA, SKYRIZI, OASIS, OTEZLA, Bimzelx.
Industry payments across AL — which companies pay providers there.
